SUB-TENON TRIAMCINOLONE ACETONIDE INJECTION IN A PREGNANT PATIENT WITH VOGT–KOYANAGI–HARADA DISEASE

    loading  Checking for direct PDF access through Ovid

Abstract

Purpose:

To report a case of new-onset Vogt–Koyanagi–Harada disease treated with sub-Tenon injection of triamcinolone acetonide in a 16-week pregnant patient.

Methods:

Review of clinical records.

Results:

A 33-year-old woman in her 16th week of pregnancy presented with bilateral serous retinal detachments associated with anterior chamber inflammation. Enhanced depth imaging optical coherence topography showed marked choroidal thickening. Headache and tinnitus developed 3 days later. The patient was diagnosed with incomplete Vogt–Koyanagi–Harada disease and treated with bilateral sub-Tenon triamcinolone acetonide injections. Within 2 weeks, the serous retinal detachments completely resolved with decreased choroidal thickness in both eyes. No recurrence of inflammation or choroidal thickening was noted over a follow-up of 13 months. The patient delivered a healthy baby at 41 weeks of pregnancy.

Conclusion:

Sub-Tenon triamcinolone acetonide injection may be an effective and safe treatment in pregnant women with new-onset Vogt–Koyanagi–Harada disease.

Related Topics

    loading  Loading Related Articles